13 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 13 of 13 clinical reviews.
Complete caregiver guide for administering isotretinoin to adolescents aged 12-17, covering iPLEDGE requirements, dosing schedules, side effect management, and monthly monitoring steps backed by FDA guidance and clinical evidence.
A clinically detailed review of how isotretinoin affects bone growth, mental health, endocrine function, and neurodevelopment in adolescents aged 12-17, with dosing guidance, monitoring protocols, and safety data.
A guide for teens on isotretinoin covering school attendance, physical activity, sun exposure, iPLEDGE compliance, and practical daily management during the 16-to-24-week course.
A guide to isotretinoin use in adults aged 65 and older, covering how daily activities, exercise, driving, and cognitive demands are affected during a typical treatment course.
A guide covering how isotretinoin affects school performance, physical activity, sun exposure, and daily routines in children under age 12, with evidence-based management strategies.
A clinical guide to isotretinoin use in adolescents ages 12 to 17, covering iPLEDGE requirements, dosing, lab monitoring, mental health considerations, and how to plan a safe handoff to adult dermatology care.
A guide for caregivers managing isotretinoin therapy in patients aged 65 and older, covering iPLEDGE requirements, dose adjustments, drug interactions, and monitoring protocols specific to the geriatric population.
Accutane's age limit: isotretinoin is FDA-approved from age 12 and up for severe nodular acne; under-18s need parent or guardian consent through iPLEDGE.
A clinical guide to isotretinoin use in patients aged 65 and older, covering pharmacokinetics, organ-system risks, drug interactions, and prescribing considerations specific to the geriatric population.
A guide covering isotretinoin use in children under 12, including dosing, iPLEDGE requirements, monitoring protocols, and how to transition young patients safely to adult dermatology care.
A comprehensive clinical review of isotretinoin's developmental effects in children under 12, covering bone growth, neurodevelopment, teratogenicity, and FDA prescribing guidance for this age group.
Complete caregiver guidance for administering isotretinoin to children under 12, including dosing schedules, iPLEDGE requirements, side effect monitoring, and safe-handling protocols reviewed by board-certified physicians.
A clinically detailed guide to isotretinoin use in adults aged 65 and older, covering iPLEDGE enrollment, dose adjustments, drug interactions, organ-system monitoring, and the transition from pediatric or young-adult dermatology care to geriatric-focused management.